Hepatitis C genotype and drug resistance testing
Consultant/s: Imperial College Molecular Diagnostic Unit (unit manager: Steve Kaye)
Expertise: Virus genotyping, drug resistance testing
Therapy with direct-acting antiviral (DAA) drugs, a new type of Hepatitis C virus (HCV) treatment that targets the viral life cycle to inhibit viral production, is being rolled out globally. However, the efficacy of the treatment depends on the virus subtype, therefore it is important to determine the HCV genotype in advance of DAA therapy to ensure the patient will actually respond to this very costly treatment.
Additionally, sequence changes in the viral genome are associated with decreased susceptibility of the Hepatitis C Virus to DAAs. Detection of these mutations in the viral genome can be used to predict the susceptibility of the virus to currently licensed DAAs and thus can be used to optimise the use of DAA treatment on an individual patient basis.
Genotyping and resistance testing are complex laboratory methods and are carried out in specialist units. The Molecular Diagnostics Unit (MDU) is developing new methods to address the challenges of HCV genotyping and resistance testing including…
- Sequencing from dried blood spots. The major advantages over liquid blood samples are the smaller quantity required and easier and safer shipping.
- Sequencing by next generation sequencing (NGS). Conventional gene sequencing (Sanger sequencing) is limited in its ability to detect drug resistance variants in a background of drug sensitive virus. NGS is much more sensitive, detecting down to 1% minority resistant variants.
In addition to testing for genotype and resistance, the team also offers bespoke training and advice in setting up similar testing facilities worldwide.
- Savings for healthcare systems
- Public health benefits for countries with high prevalence of Hepatitis C – and their neighbours.
Related case studies
The consultants shared their expertise in seismic assessment and design to support the development of EN1998, also known as Eurocode 8. read more
When Left Bank Pictures (producers of The Crown and Lost) were looking for someone to give their Sci fi adventure, ORIGIN, a touch of realism - they called upon Imperial Consultants. Thanks to his previous work with filmmakers, writers and artists, they were introduced to Dr Roberto Trotta, a theoretical cosmologist renowned for taking on the unusual - and gifted in translating ‘science-speak’ into layman’s terms. read more
Imperial's facility, comprising the UKAS accredited Molecular Diagnostic Unit (MDU) and high-throughput robotic platform for RNA extraction, forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, set-up by MedCity. read more